Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial

Table 1 Measures

	Study period
	Screening	Baseline (day 1)	Check-in call 1 (days 9–15)	Check-in call 2 (days 22–28)	Final follow-up (7 months post randomization)
Enrolment
Eligibility screen	X
Informed consent	X
Treatment allocation (randomization)		X
Assessments
Demographic information: age, sex, postcode, receipt of government pension	X
Sociodemographic information: ancestry, education, marital status, family composition		X
Socioeconomic demographics: employment status, income		X			X
Study treatment adherence			X	X	X
Adverse events			X	X	X
Self-reported abstinence			X	X	X
Smoking information: daily consumption, withdrawal symptoms, urges [26]		X	X	X	X
Smoking (and quitting) history, self-efficacy, attitude, identity [27,28,29,30]		X
Financial stress [31, 32]		X			X
Alcohol use (AUDIT-C) [33]		X	X	X
Cannabis use and drug/alcohol treatment		X
Psychological distress (K10) [34]		X
Quality of Life (EQ5D-5L) [35]		X			X
Respiratory symptoms [36, 37]		X	X	X	X
Study treatment feedback					X
Acceptability of text message support					X
Concomitant medications	X		X	X
Carbon monoxide verified abstinence					X

ISSN: 1745-6215